• Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

DPRM:IT

21.10 ILs 0.60 2.76%

As of 07:24:44 ET on 04/17/2014.

Snapshot for D-Pharm Ltd (DPRM)

Open: 21.70 Day's Range: 20.90 - 21.30 Volume: 203,682
Previous Close: 21.70 52wk Range: 15.67 - 51.58 1-Yr Rtn: -57.91%

Stock Chart for DPRM

No chart data available.
  • DPRM:IT 20.90
  • 1D
  • 1M
  • 1Y
21.70
Interactive DPRM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DPRM

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. TA-100 -
Earnings Per Share (ttm) -0.1522
Est. EPS -
Est. PEG Ratio -
Market Cap (M ILS) 18.60
Shares Outstanding (M) 88.15
30 Day Average Volume 1,335,873
Price/Book (mrq) 0.7781
Price/Sale (ttm) 13.4269
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DPRM

  • Revenue
  • Net Income (M/ILS)
  • Profit Margin (%)

Company Profile & Key Executives for DPRM

D-Pharm Ltd. is a biopharmaceutical company. The Company is developing drugs to treat epilepsy, stroke, Alzheimer's disease, cancer, and AIDS.

Alexander KozakPresident/CEO/FounderOfra YaminCFO & Human Resources
Gilad RosenbergVP:Clinical Development
More Company Profile & Key Executives for DPRM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil